Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKeywords Studios Plc Regulatory News (KWS)

Share Price Information for Keywords Studios Plc (KWS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,166.00
Bid: 1,156.00
Ask: 1,160.00
Change: 7.00 (0.60%)
Spread: 4.00 (0.346%)
Open: 1,157.00
High: 1,166.00
Low: 1,130.00
Prev. Close: 1,159.00
KWS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Keywords Studios (KWS): Looking like a winner as the dust settles

2 Mar 2021 07:00

Edison Investment Research Limited Keywords Studios (KWS): Looking like a winner as the dust settles 02-March-2021 / 07:00 GMT/BST


 

London, UK, 2 March 2021

 

Keywords Studios (KWS): Looking like a winner as the dust settles

Buoyed by exceptional demand for games during lockdown and boosted by the start of the console transition, the global games industry showed year-on-year growth of 20% in FY20 (Newzoo). Benefiting from increased industry development spending and the growth in new releases, Keywords delivered underlying organic revenue growth of 12%, with FY20 revenues rising 14% y-o-y. Assuming no worsening impact from COVID-19, FY21 looks set to be a more settled year. With publishers launching increasing numbers of new titles to address a growing next-gen console base in FY21-23, demand for Keywords' services should continue to build in the short to medium term. The outlook for Keywords appears positive and, with net cash of c €100m (plus €100m of undrawn facilities), Keywords remains well placed to participate in earnings-enhancing M&A.

 

Keywords' shares trade on an FY21e P/E of 38.9x, falling to 34.5x in FY22e, in line with its UK games industry peers. Although this is a demanding valuation, we expect the recent next-gen console launches to lead to a period of heightened game releases, benefiting underlying demand in the period FY21-23e. When complemented by Keywords' proven accretive buy-and-build strategy, this should further reduce valuation multiples. 

Click here to view the full report or here to sign up to receive research as it is published.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector. Headquartered in London, Edison also has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in Athens, Johannesburg and Sydney.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Richard Williamson +44 (0)20 3077 5700 tech@edisongroup.com

Dan Ridsdale +44 (0)20 3077 5729 tech@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-group-/

Twitter  www.twitter.com/Edison_Inv_Res

YouTube  www.youtube.com/edisonitv


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1172241 02-March-2021 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
1st May 20247:00 amRNSTotal Voting Rights
29th Apr 20242:37 pmRNSBlock Admission
19th Apr 20243:59 pmRNSPublication of Annual Report and Accounts
10th Apr 20247:46 amRNSIssue of Shares
2nd Apr 20247:00 amRNSTotal Voting Rights
22nd Mar 20242:15 pmRNSHolding(s) in Company
14th Mar 20247:00 amRNSIssue of Shares
13th Mar 20247:00 amRNSFinal Results
6th Mar 20243:51 pmRNSDirector/PDMR Shareholding
1st Mar 20247:00 amRNSTotal Voting Rights
6th Feb 20247:00 amRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSTotal Voting Rights
25th Jan 20247:00 amRNSFull Year Trading Update
9th Jan 20247:00 amRNSAppointment of Joint Corporate Broker
2nd Jan 20244:14 pmRNSTotal Voting Rights
2nd Jan 20249:45 amRNSIssue of Shares
18th Dec 20237:00 amRNSAcquisition
6th Dec 20234:26 pmRNSIssue of Shares
1st Dec 20237:00 amRNSTotal Voting Rights
16th Nov 20239:37 amRNSIssue of Shares
13th Nov 20237:00 amRNSBlock listing return
8th Nov 20237:00 amRNSDirector/PDMR Shareholding
1st Nov 20235:11 pmRNSTotal Voting Rights
26th Oct 20231:57 pmRNSHolding(s) in Company
24th Oct 20232:54 pmRNSHolding(s) in Company
18th Oct 20237:00 amRNSDirector Share Purchase
2nd Oct 20231:34 pmRNSTotal Voting Rights
26th Sep 20233:35 pmRNSHolding(s) in Company
20th Sep 20232:48 pmRNSDirector/PDMR Shareholding
19th Sep 20234:35 pmRNSHolding(s) in Company
19th Sep 20234:30 pmRNSHolding(s) in Company
14th Sep 202310:21 amRNSHolding(s) in Company
12th Sep 20237:00 amRNSInterim Results
5th Sep 20235:26 pmRNSHolding(s) in Company
1st Sep 20237:00 amRNSTotal Voting Rights
11th Aug 202312:42 pmRNSDirector/PDMR Shareholding
4th Aug 20239:00 amRNSDirector/PDMR Shareholding
1st Aug 20233:12 pmRNSDirector Share Purchase
1st Aug 20239:57 amRNSTotal Voting Rights
1st Aug 20237:00 amRNSH1 Trading Update
28th Jul 20237:37 amRNSIssue of Shares
25th Jul 202310:42 amRNSHolding(s) in Company
21st Jul 20237:00 amRNSNew Revolving Credit Facility of $400 million
3rd Jul 202311:26 amRNSTotal Voting Rights
3rd Jul 202310:25 amRNSHolding(s) in Company
21st Jun 20237:00 amRNSAppointment of Chief Financial Officer
19th Jun 20232:59 pmRNSHolding(s) in Company
14th Jun 20237:00 amRNSExtension of EBT Market Purchases to EUR15 million
12th Jun 20237:16 amRNSIssue of Shares
9th Jun 20237:00 amRNSDirector Share Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.